Rui Avelar's Net Worth

$5.35 Million

Estimate Recalculated Mar 29, 2024 06:09PM EST

Who is Rui Avelar?

Rui Avelar has an estimated net worth of $5.35 Million. This is based on reported shares across multiple companies, which include Evolus, Inc., and ANGIOTECH PHARMACEUTICALS INC.

SEC CIK

Rui Avelar's CIK is 0001432063

Past Insider Trading and Trends

2020 was Rui Avelar's most active year for acquiring shares with 3 total transactions. Rui Avelar's most active month to acquire stocks was the month of December. 2009 was Rui Avelar's most active year for disposing of shares, totalling 2 transactions. Rui Avelar's most active month to dispose stocks was the month of December. 2019 saw Rui Avelar paying a total of $99,999.60 for 70,020 shares, this is the most they've acquired in one year. In 2020 Rui Avelar cashed out on 39,442 shares for a total of $422,281.83, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Evolus, Inc. (EOLS) Snapshot price: $13.02

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-6.90%
-27.60K
$13.92
-$384,349.69
372.29K
Mar 19
Form 4
+2.91%
11.29K
$13.08
-$23,820.87
399.89K
Scheduled
Feb 21 - Feb 22
Form 4
+9.96%
35.21K
—
—
388.6K
Feb 7
Form 4
+5.20%
17.46K
$10.27
-$22,706.97
353.39K
Aug 14 - Aug 16
Form 4
-4.25%
-14.91K
$8.47
-$126,237.42
335.93K
Scheduled
Mar 14
Form 4
+38.56%
97.64K
—
—
350.83K
Jan 25
Form 4
-3.87%
-10.19K
$9.73
-$99,121.28
253.19K
Scheduled
Mar 8
Form 4
+25.53%
53.57K
—
—
263.38K
Jan 24
Form 4
-6.38%
-14.29K
$11.18
-$159,788.59
209.81K
Scheduled
Aug 10
Form 4
+67.11%
90K
—
—
224.1K
Jan 27
Form 4
-1.97%
-2.70K
$7.46
-$20,134.54
134.1K
Scheduled
Jan 25
Form 4
+41.32%
40K
—
—
136.8K
May 13
Form 4
+36.72%
26K
—
—
96.8K
Jan 23
Form 4
-35.78%
-39.44K
$10.71
-$422,281.83
70.8K
Scheduled
Jan 7
Form 4
+10.00%
10.02K
$9.98
$99,999.60
110.24K
Dec 10
Form 4
—
0
—
—
0
Jan 23
Form 3
—
0
—
—
0
No matching records found

ANGIOTECH PHARMACEUTICALS INC No price found

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 8
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Dec 8
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found